Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EVT
EVT logo

EVT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
26.045
Open
25.990
VWAP
25.97
Vol
41.69K
Mkt Cap
--
Low
25.900
Amount
1.08M
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Eaton Vance Tax-Advantaged Dividend Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return consisting primarily of tax-advantaged dividend income and capital appreciation. It pursues its objective by investing primarily in dividend-paying common and preferred stocks. In addition to investing in stocks that pay tax-advantaged dividends, it may also invest a portion of its assets in stocks and other securities (including preferred stocks, hybrid securities, or bonds) that generate fully taxable ordinary income (income other than tax-advantaged dividends). The Fund may invest in common and preferred stocks of both domestic and foreign issuers. Preferred stocks may include other hybrid securities. The Fund can invest up to 10% of its net assets in exchange-traded funds (ETFs) that invest primarily in preferred stocks. Investment advisor of the Fund is Eaton Vance Management.
Show More

Events Timeline

No data

No data

News

Yahoo Finance
5.0
04-15Yahoo Finance
Evotec Appoints New Chief Operating Officer
  • Executive Appointment: Evotec announced the appointment of Dr. Ingrid Müller as Chief Operating Officer, effective May 1, 2026, bringing over 20 years of international leadership experience to oversee global operations and the execution of the Horizon initiative.
  • Strategic Execution: In her previous role as Vice President at CureVac, Dr. Müller successfully drove portfolio strategy and execution, and in senior roles at Sanofi and Fresenius Kabi, she strengthened supply chain resilience and achieved annual savings.
  • Operational Efficiency Enhancement: As COO, Dr. Müller will focus on improving quality, productivity, and delivery capabilities, with expectations that her extensive operational and strategic background will drive Evotec's growth transformation and enhance its competitiveness in the life sciences sector.
  • Global Team Collaboration: Dr. Müller expressed her eagerness to collaborate with the global team to further enhance operational excellence and quality, supporting Evotec's sustainable growth and reflecting the company's commitment to scientific and technological platforms.
Newsfilter
8.0
04-01Newsfilter
Eaton Vance Funds Announce Distribution Plans
  • Distribution Announcement: Eaton Vance Funds announced distributions on April 1, 2026, covering various municipal and taxable funds, demonstrating the company's ongoing commitment to providing cash flow to investors.
  • Municipal Bond Fund Distribution: Eaton Vance California Municipal Income Trust (CEV) will distribute $0.0500 per share, with a market price of $10.07 and a distribution rate of 5.96%, reflecting stable earning capacity and market confidence.
  • Taxable Fund Dynamics: Eaton Vance Senior Income Trust (EVF) will distribute $0.0330 per share, down $0.0060 from the prior distribution, with a market price of $4.99 and a distribution rate of 7.94%, indicating the impact of market volatility on distributions.
  • Managed Distribution Plan: Eaton Vance Funds operate under a managed distribution plan to ensure regular cash distributions, although distributions may exceed net investment income, requiring investors to carefully assess risks and returns.
Newsfilter
8.0
04-01Newsfilter
Eaton Vance Funds Release Estimated March 2026 Distribution Sources
  • Distribution Plan Implementation: The Board of Trustees of Eaton Vance Funds has approved a managed distribution plan, with a March 2026 distribution amount of $0.1338 per share, aimed at providing consistent cash flow to common shareholders and enhancing investor confidence.
  • Transparent Distribution Sources: The funds report that 100% of the distribution comes from long-term capital gains, despite no net investment income, indicating a strategic approach to capital management that may influence investor expectations regarding long-term performance.
  • Market Condition Impact: The total distribution amounts for each fund are subject to change due to market conditions, reminding investors to stay alert to market dynamics to adjust their investment strategies accordingly and maximize returns.
  • Tax Information Disclosure: The reported distribution amounts are estimates, with actual tax reporting dependent on the funds' investment performance, prompting investors to pay attention to the 1099-DIV forms to ensure compliance and avoid potential tax risks.
Yahoo Finance
5.0
04-01Yahoo Finance
Evotec Appoints New Chief Commercial Officer
  • Executive Appointment: Evotec SE has appointed Dr. Ashiq H. Khan as Chief Commercial Officer, who brings over 15 years of international leadership experience and will lead the development of a globally integrated commercial organization aligned with the company's scientific leadership to enhance customer value and drive sustainable growth.
  • Extensive Industry Experience: Dr. Khan has a distinguished track record in biotech, CRO, and AI-driven platforms, having successfully managed transcontinental teams and closed over $7 billion in high-value agreements, which will significantly bolster Evotec's commercial strategy.
  • Innovation-Driven Transformation: CEO Dr. Christian Wojczewski emphasized that Dr. Khan's success in robotics, AI, and drug discovery platforms is crucial for executing the next phase of Evotec's transformation into a responsive drug discovery and development engine focused on high-value services.
  • Integration of Technology and Science: Dr. Khan stated that Evotec is uniquely positioned to advance early-stage drug discovery and development, leveraging industry-validated platforms and deep scientific expertise to drive the next generation of breakthrough therapies, thereby enhancing the company's competitive edge in the market.
Yahoo Finance
9.0
03-19Yahoo Finance
Evotec and BMS Initiate Phase 1 Clinical Trial for Kidney Cancer Treatment
  • Clinical Trial Launch: The initiation of Phase 1 clinical trial for BMS-986506 in advanced clear cell renal cell carcinoma marks a significant advancement in the strategic collaboration between Evotec and BMS, potentially establishing a new treatment paradigm for kidney cancer.
  • Milestone Payment: Evotec will receive a $10 million milestone payment as a result of this clinical progression, which not only strengthens the company's financial position but also reflects its technological prowess in the protein degradation field.
  • Technology Validation: The trial validates Evotec's capabilities in high-performance multi-omics screening and AI-supported data analytics, showcasing its potential in developing novel molecular glue drugs that could reshape cancer treatment standards.
  • Deepening Strategic Collaboration: Since the partnership with BMS began in 2018, Evotec has been advancing molecular glue drug development through its PanOmics and PanHunter platforms, aiming to address significant unmet medical needs and further solidify its leadership in the biopharmaceutical sector.
Newsfilter
8.0
03-02Newsfilter
Eaton Vance Funds Announce Distribution Plans
  • Distribution Announcement: Eaton Vance Funds announced distributions on March 2, 2026, covering various municipal and taxable funds, reflecting the company's ongoing efforts to maintain stable cash flows, which is expected to bolster investor confidence.
  • Municipal Bond Fund Distributions: The Eaton Vance California Municipal Income Trust (CEV) declared a distribution of $0.0500 per share with a market price of $10.63, resulting in a distribution rate of 5.64%, indicating the fund's ability to sustain relatively stable returns in the current market environment.
  • Taxable Fund Performance: The Eaton Vance Senior Income Trust (EVF) announced a distribution of $0.0390 per share at a market price of $5.09, yielding a distribution rate of 9.19%, showcasing strong performance in income distribution that may attract more investors seeking stable income.
  • Managed Distribution Plan: Eaton Vance Funds operate under a managed distribution plan, ensuring transparency and enhancing investor understanding of fund performance, although distributions may exceed net investment income, prompting investors to carefully assess associated risks.
Wall Street analysts forecast EVT stock price to rise
0 Analyst Rating
Wall Street analysts forecast EVT stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Eaton Vance Tax-Advantaged Dividend Income Fund (EVT.N) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Eaton Vance Tax-Advantaged Dividend Income Fund's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding EVT

M
Mutual Trust Pty Ltd
Holding
EVT
+35.11%
3M Return
P
Perpetual Limited
Holding
EVT
+6.23%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Eaton Vance Tax-Advantaged Dividend Income Fund (EVT) stock price today?

The current price of EVT is 25.965 USD — it has increased 0.02

What is Eaton Vance Tax-Advantaged Dividend Income Fund (EVT)'s business?

Eaton Vance Tax-Advantaged Dividend Income Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return consisting primarily of tax-advantaged dividend income and capital appreciation. It pursues its objective by investing primarily in dividend-paying common and preferred stocks. In addition to investing in stocks that pay tax-advantaged dividends, it may also invest a portion of its assets in stocks and other securities (including preferred stocks, hybrid securities, or bonds) that generate fully taxable ordinary income (income other than tax-advantaged dividends). The Fund may invest in common and preferred stocks of both domestic and foreign issuers. Preferred stocks may include other hybrid securities. The Fund can invest up to 10% of its net assets in exchange-traded funds (ETFs) that invest primarily in preferred stocks. Investment advisor of the Fund is Eaton Vance Management.

What is the price predicton of EVT Stock?

Wall Street analysts forecast EVT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EVT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Eaton Vance Tax-Advantaged Dividend Income Fund (EVT)'s revenue for the last quarter?

Eaton Vance Tax-Advantaged Dividend Income Fund revenue for the last quarter amounts to NaN USD, decreased

What is Eaton Vance Tax-Advantaged Dividend Income Fund (EVT)'s earnings per share (EPS) for the last quarter?

Eaton Vance Tax-Advantaged Dividend Income Fund. EPS for the last quarter amounts to USD, decreased

How many employees does Eaton Vance Tax-Advantaged Dividend Income Fund (EVT). have?

Eaton Vance Tax-Advantaged Dividend Income Fund (EVT) has 0 emplpoyees as of April 20 2026.

What is Eaton Vance Tax-Advantaged Dividend Income Fund (EVT) market cap?

Today EVT has the market capitalization of 0.00 USD.